JHIU
SNOA icon

Janus Henderson Investors US’s Sonoma Pharmaceuticals SNOA Stock Holding History

Janus Henderson Investors US’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$272K Buy
211
+62
+42% +$72.1K ﹤0.01% 1125
2016
Q4 		$135K Buy
+149
New +$124K ﹤0.01% 1194

Other funds holding SNOA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Investors US's SNOA Position: Q1 2017 in Review

Janus Henderson Investors US increased its Sonoma Pharmaceuticals (SNOA) stake by 42% in Q1 2017, buying an estimated $72.1K and bringing the position to 211 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #1125.

Janus Henderson Investors US first reported a position in SNOA in Q4 2016 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold SNOA as of Q1 2017.

  • Janus Henderson Investors US held 211 shares of Sonoma Pharmaceuticals worth $272K as of Q1 2017.
  • Janus Henderson Investors US bought 62 Sonoma Pharmaceuticals shares in Q1 2017, an estimated $72.1K.
  • Sonoma Pharmaceuticals made up ﹤0.01% of Janus Henderson Investors US's portfolio in Q1 2017, its #1125 holding.
  • Janus Henderson Investors US first reported a position in Sonoma Pharmaceuticals in Q4 2016 and has held it in 2 quarters since.
  • 19 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.